Quantcast Early Abciximab Has Benefits In High-Risk STEMI Patients: Study - Congoo
 
 
Log In
Early abciximab has benefits in high-risk STEMI patients: study
Have an interest in this Story?
Sign Up for Real-Time email updates
Reuters Health  | November 07, 2009

NEW YORK (Reuters Health) - Giving abciximab to high-risk patients with ST-elevation myocardial infarction (STEMI) before transferring them for percutaneous coronary intervention (PCI) reduces 1-year mortality without increasing bleeding complications, new research shows. This finding, reported in t...
Read Full Article   
 
Leave a Comment: You must be logged in to leave a comment     Log in | Register
 

Featured Members
Mark Palmer Mark Palmer
Founder
Internet consultancies
Matthew Clark Matthew Clark
Mentor
Entrepreneur

  
  View more profiles

 
Access dozens of premium and subscriptions sites Free! Download now.

Advertise   |   Build a News Circle   |   Get News Briefings   |   Congoo News Home   |   Get the Netpass
About Congoo   |   Terms   |   Privacy   |   Need Help?   |   Site Map
Copyright ©2009 Congoo.com. All Rights Reserved.